Observational studyJournal of cosmetic dermatology2025
Long-Pulsed Alexandrite Laser for Scrotal Angiokeratomas: Efficacy and Safety in a Clinical Study.
Observational study in Journal of cosmetic dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Long-Pulsed Alexandrite Laser for Scrotal Angiokeratomas: Efficacy and Safety in a Clinical Study.Journal of cosmetic dermatology · 2025Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionScrotal angiokeratomas or Angiokeratoma of Fordyce (AF) are benign vascular lesions that may cause cosmetic concerns and recurrent bleeding, prompting patients to seek treatment. Various laser modalities have been explored for their management, but data on the efficacy of the long-pulsed alexandrite laser (755 nm) in treating symptomatic cases remain limited.
objectiveThis study aimed to evaluate the efficacy and safety of long-pulsed alexandrite laser for the treatment of symptomatic AF.
methodsThis was a nonrandomized interventional observational study conducted at a dermatology clinic in a private hospital. Ten symptomatic male patients (n = 10; aged 25-67 years) with histologically confirmed scrotal angiokeratomas underwent two to three sessions of long-pulsed alexandrite laser treatment. Clinical outcomes were assessed over a 3-month follow-up period, including lesion clearance, symptom resolution, patient satisfaction, and adverse effects. Statistical analysis was performed using the Wilcoxon signed-rank test.
resultsAmong the 10 patients, 7 (70%) achieved measurable clearance, including 5 (50%) with near-complete resolution and 2 (20%) with moderate improvement. Three patients (30%) showed no improvement in lesion clearance. Recurrent bleeding was initially reported by nine patients (90%); all experienced reduced frequency, and most reported complete cessation. Adverse effects occurred in five patients (50%), with some experiencing more than one event (erythema, scarring, or hypopigmentation), accounting for cumulative percentages exceeding 100%. A significant improvement in clearance was confirmed by the Wilcoxon signed-rank test (p = 0.0118).
conclusionLong-pulsed Alexandrite laser demonstrated high efficacy and safety in treating symptomatic scrotal angiokeratomas, achieving significant lesion clearance and symptom relief with minimal adverse effects. This study supports its role as a noninvasive alternative to surgical approaches, although larger, randomized studies are recommended to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.